| Literature DB >> 29277965 |
Meztlli O Gaytán1, Julia Monjarás Feria1, Eduardo Soto1, Norma Espinosa1, Julia M Benítez1, Dimitris Georgellis1, Bertha González-Pedrajo1.
Abstract
Type three secretion systems (T3SSs) are virulence determinants employed by several pathogenic bacteria as molecular syringes to inject effector proteins into host cells. Diarrhea-producing enteropathogenic Escherichia coli (EPEC) uses a T3SS to colonize the intestinal tract. T3S is a highly coordinated process that ensures hierarchical delivery of three classes of substrates: early (inner rod and needle subunits), middle (translocators), and late (effectors). Translocation of effectors is triggered upon host-cell contact in response to different environmental cues, such as calcium levels. The T3S substrate specificity switch from middle to late substrates in EPEC is regulated by the SepL and SepD proteins, which interact with each other and form a trimeric complex with the chaperone CesL. In this study, we investigated the link between calcium concentration and secretion regulation by the gatekeeper SepL. We found that calcium depletion promotes late substrate secretion in a translocon-independent manner. Furthermore, the stability, formation, and subcellular localization of the SepL/SepD/CesL regulatory complex were not affected by the absence of calcium. In addition, we demonstrate that SepL interacts in a calcium-independent manner with the major export gate component EscV, which in turn interacts with both middle and late secretion substrates, providing a docking site for T3S. These results suggest that EscV serves as a binding platform for both the SepL regulatory protein and secreted substrates during the ordered assembly of the T3SS.Entities:
Keywords: EPEC; EscV; SepL; T3SS; injectisome; secretion hierarchy
Mesh:
Substances:
Year: 2017 PMID: 29277965 PMCID: PMC6011996 DOI: 10.1002/mbo3.571
Source DB: PubMed Journal: Microbiologyopen ISSN: 2045-8827 Impact factor: 3.139
Strains and plasmids used in this study
| Strain/plasmid | Description | Reference |
|---|---|---|
|
| ||
| EPEC E2348/69 | WT EPEC O127:H6 strain; Smr | Levine et al. ( |
| ∆ | E2348/69 carrying an in‐frame deletion of | Gauthier et al. ( |
| ∆ | E2348/69 carrying an in‐frame deletion of | Gift of the Navarro F. Lab |
| ∆ | E2348/69 carrying an in‐frame deletion of | Gift of the Xicohtencatl J. Lab |
| ∆ | E2348/69 carrying an in‐frame deletion of | Gift of the Xicohtencatl J. Lab |
| ∆ | E2348/69 carrying an in‐frame deletion of | Gift of the Puente JL Lab |
| ∆ | E2348/69 carrying an in‐frame deletion of | Soto et al. ( |
| JPEP39 (∆ | E2348/69 carrying an in‐frame deletion of | Garcia‐Angulo et al. ( |
| EPEC | E2348/69 expressing 3‐FLAG‐tagged | This study |
| EPEC | E2348/69 expressing 2‐HA‐tagged | This study |
| EPEC | E2348/69 expressing 3‐FLAG‐tagged | This study |
| BL21(DE3)/pLysS | Strain used for expression of pET19b constructs; Cmr | Novagen |
| XL1‐Blue | Strain used for cloning; Tcr | Stratagene |
|
| ||
| JR501 | Strain used to convert plasmids to | Ryu & Hartin ( |
| SJW1368 | Strain used for expression of pTrc99A_FF4 constructs; flagellar master operon mutant, ∆(cheW‐flhD) | Ohnishi et al. ( |
|
| ||
| pTrc99A_FF4 | Modified pTrc99A expression vector under the control of the trc promoter; Apr | Ohnishi, Fan, Schoenhals, Kihara, & Macnab ( |
| pET19b | Expression vector under the control of the T7 promoter; Apr | Novagen |
| pACTrc | Expression vector under the control of the trc promoter; Cmr | Gift of the Fraser GM Lab |
| pKD46 | Red recombinase system plasmid under the control of the | Datsenko & Wanner ( |
| pSUB11 | Template plasmid for amplification of 3‐FLAG‐kanamycin‐resistance cassette; Apr, Kmr | Uzzau et al., ( |
| pSU315 | Template plasmid for amplification of HA‐kanamycin‐resistance cassette; Apr, Kmr | Uzzau et al. ( |
| pFLP2 | Flp recombinase expression plasmid; Apr | Hoang et al. ( |
| pMTpL |
| This study |
| pMTpL∆C75 |
| This study |
| pMTpL∆C11 |
| This study |
| pKEeVc |
| This study |
| pKTeDN |
| This study |
| pKEeDN |
| This study |
| pJEeI |
| Monjaras Feria et al. ( |
| pETeI |
| This study |
| pSLo4 |
| Soto et al. ( |
| pJHeH |
| Monjaras Feria et al. ( |
| pJHnC |
| Monjaras Feria et al. ( |
| pJHeI |
| Monjaras Feria et al. ( |
| pJHnH2 |
| Monjaras Feria et al. ( |
| pATpD |
| This study |
| pMEcL |
| This study |
| pMTBISpDcL |
| This study |
| pMATpL |
| This study |
| pMATpL∆C11 |
| This study |
Oligonucleotides used in this study
| Oligonucleotide | Sequence 5′ – 3′ |
|---|---|
| sepL_Fw | AGTTTCATATGGCTAATGGTATTG |
| sepL_Rv | CTATAAAAAAAAGGATCCTCACAT |
| sepL∆C75_Rv | TAGCATGGATCCTCAAATGACATC |
| sepL∆C11_Rv | AATCTATGGATCCTCAAATCATTA |
| sepD_Fw | TAATACATATGAACAATAATAATG |
| sepD_Rv | AAAAACTTATTGGATCCATTACAC |
| cesL_Fw | AGAGCCTGCATATGAATCTTTTAG |
| cesL_Rv | ATTTAAGAGGATCCTCATGATGTC |
| escV_CtermFw | AATAATAAGGATCATATGGGAGCTGATTTG |
| escV_CtermRv | GTGGGTATGGATCCAATACAGAATC |
| escD_Fw | GGATGAATAAAATTTACATATGTTATCCTCATATAA |
| escD_Nterm_Rv | CTCGCCAGGATCCGGCGTTATTTGC |
| sepL‐3FLAG_Fw | ATACATTATTAATGATTGGTAAAGTGATAGATTATAAGGAGGATGTTATGGACTACAAAGACCATGACGG |
| sepL‐FLAG_Rv | CCTCTTCATAATCTTTCTTAGCATGACAAAAACTATAAAAAAAAACAATAATGAATATCCTCCTTAGTTC |
| cesL‐2HA_Fw | CTTTTCAACAGCATGTGCAGATTATTGAGCGCGTTCGCAGGATGACATCATATCCGTATGATGTGCCGGACTATGCGTATCCGTATGATGTTCCTGAT |
| cesL‐2HA_Rv | AAGATCGTGATATGACTCTGCTTTTTTAAATATATTTAAGAGTTTATTCATATGAATATCCTCCTTAGTTC |
Figure 1Calcium depletion from the bacterial growth media enhances effector secretion. (a) T3 secretion profiles of the EPEC wild‐type strain (WT) grown in regular DMEM containing 1.8 mmol/L of CaCl2 (Regular), calcium‐free DMEM (Ca2+‐free) or calcium‐free DMEM supplemented with 1.8 mmol/L of CaCl2 (Ca2+‐free + Ca2+), and the ∆sepL and ∆escU mutant strains, visualized by SDS‐PAGE stained with Coomassie brilliant blue (CBB) (upper panel). The presence of DnaK, Tir, Map, and EspA in the supernatants (SN) and whole‐cell lysates (WC) was examined by immunoblotting, using anti‐DnaK, anti‐Tir, anti‐Map, and anti‐EspA antibodies (lower panels). (b) Protein secretion profiles of EPEC WT strain overproducing HA‐tagged T3 substrates, grown in the presence or absence of calcium as described in (a). Immunodetection of LEE and non‐LEE‐encoded effectors (NleH2, EspH, and NleC) and the inner rod protein EscI, was performed in the supernatants (SN) and whole‐cell lysates (WC) using specific antibodies against the HA tag. The results shown are representative of three independent experiments. (c) Relative abundance of EspA and Tir proteins in the supernatant of EPEC wild‐type strain grown in the presence or absence of calcium as described in (a). CBB‐stained protein bands were quantified from six independent secretion assays by gel densitometry using the ImageJ software (Schneider, Rasband, & Eliceiri, 2012). The secretion level of EspA and Tir proteins was normalized relative to the secretion level of the EspC autotransporter band. The average and the standard deviation of normalized data are displayed. Significant statistical differences compared with the regular DMEM condition are denoted by asterisks. A p value < .05 was considered statistically significant. ** p = .002, Wilcoxon‐test
Figure 2The translocon components EspA, EspB, and EspD are dispensable for calcium sensing. The secretion profiles of the EPEC wild‐type strain (WT) and the ∆espA, ∆espB, and ∆espD null mutants grown under T3S inducing conditions in the presence or absence of calcium were analyzed by Coomassie brilliant blue stained SDS‐PAGE (upper panel). Immunodetection of secreted proteins (SN) and whole‐cell lysates (WC) was performed using specific antibodies against Tir and DnaK (bottom panel)
Figure 3The SepL/SepD/CesL complex does not participate in the calcium‐absence response. (a) Immunoblot analysis of whole‐cell lysates of the EPEC sepL‐3FLAG cesL‐2HA strain grown under T3S inducing conditions in the presence or absence of calcium. Intracellular protein stability of SepL‐3FLAG and CesL‐2HA was examined every 30 min during 3 hr after the addition of chloramphenicol, by immunodetection using anti‐FLAG and anti‐HA antibodies. Anti‐DnaK was used as a loading control. (b) Immunoprecipitation of SepL‐3FLAG from the EPEC sepL‐3FLAG cesL‐2HA and EPEC cesL‐2HA strains grown in the presence or absence of calcium. Coimmunoprecipitation of SepD, CesL‐2HA, and DnaK with SepL‐3FLAG was corroborated with specific antibodies against SepD, HA‐tag, and DnaK. (c) The EPEC sepL‐3FLAG cesL‐2HA strain grown in the presence or absence of calcium was fractionated into cytoplasmic (C) and membrane (M) fractions. Immunodetection of SepL‐3FLAG and CesL‐2HA in the cell lysate (Lys) and in the cytoplasmic and membrane fractions was performed using antibodies against the FLAG and HA tags. To confirm proper fractionation, samples were probed with anti‐DnaK and anti‐EscJ antibodies as cytoplasmic and membrane markers, respectively
Figure 4EscVc directly interacts with secreted proteins. Pull‐down assay of His‐EscVc (left panels) and His‐EscD (middle panels) with secreted proteins, performed by nickel affinity chromatography. The cleared lysate containing His‐EscVc or His‐EscD (Lys), was incubated with Ni‐NTA beads and loaded into a column. The proteins secreted into the supernatant by the ∆sepL and ∆grlR null mutant strains (SN) were passed through the His‐EscVc or His‐EscD‐coupled resin in the column and the flow through (FT) was collected. After extensive washing (W), proteins were eluted (E1 and E2). Samples were visualized by SDS‐PAGE stained with Coomassie brilliant blue (CBB) (upper panels). Detection of copurified proteins was performed by immunoblotting with specific antibodies against Tir, EspD, and EspA (lower panels). As an additional control, the nonspecific binding of Tir, EspD, and EspA to the Ni‐NTA beads was analyzed by SDS‐PAGE stained with CBB and immunoblotting (right panels)
Figure 5SepL interacts with the export gate component EscV. (a) Pull‐down assays of His‐EscVc and SepL (His‐EscVc + SepL) performed by nickel affinity chromatography in the presence or absence of 2 mmol/L CaCl2. Cleared lysates containing His‐EscVc or untagged SepL were mixed and incubated for 2 hr (In) in the absence or presence of calcium. Samples were loaded into columns packed with Ni‐NTA resin, washed (W) and eluted (E1, E2, and E3). His‐EscVc was visualized by SDS‐PAGE stained with Coomassie brilliant blue (CBB). The molecular mass markers (M) of 37 and 50 kDa are shown. Detection of copurified SepL was performed by immunoblotting with polyclonal antibodies against SepL (middle panel). As a negative control, SepL was loaded into a Ni‐NTA column (Ni‐NTA + SepL) and treated under the same conditions described above (lower panel). (b) Pull‐down assays of His‐EscVc and C‐terminal truncated versions of SepL (SepL∆C75 and SepL∆C11) performed by nickel affinity chromatography. Cleared lysates containing His‐EscVc and full‐length SepL (SepL), SepL∆C75, or SepL∆C11 were mixed and incubated for 2 hr (Lys). Samples were loaded into columns packed with Ni‐NTA resin, washed (W), and eluted (E). His‐EscV was visualized by SDS‐PAGE stained with CBB. Copurified proteins were detected by immunoblotting using polyclonal anti‐SepL antibodies (middle panels). As negative controls, the nonspecific binding of SepL, SepL∆C75, and SepL∆C11 to the Ni‐NTA resin was analyzed by immunoblotting (lower panels). (c) Protein secretion profiles of EPEC wild‐type (WT), ∆escN and ∆sepL mutant strains, and the ∆sepL strain carrying the empty vector pTrc99A_FF4 (pTrc99A), or the pTrc99A_FF4‐based plasmids expressing sepL or the C‐terminal truncated versions sepL ∆C75 and sepL ∆C11. Secreted proteins were visualized by SDS‐PAGE stained with CBB (upper panel) and detected by immunoblotting in the supernatants (SN) with specific antibodies against Tir and EspA. The production of SepL and its truncated versions in whole‐cell lysates (WC) was examined by immunoblotting with polyclonal antibodies against SepL
Figure 6SepL protein–protein interaction network involved in middle and late substrate secretion regulation. (a) The SepL protein binds directly to five different T3SS components: SepD, EscP, Tir, EscD, and EscV. Although SepL forms a ternary complex with SepD and CesL (Younis et al., 2010), no direct interaction between CesL (dashed circle) and SepL or SepD has been reported. The effector Tir binds to its cognate chaperone CesT (Elliott et al., 1999), which in turn has been demonstrated to interact with EscP (Monjaras Feria et al., 2012). Finally, the interaction between EscV and different T3S substrates is also displayed. (b) Schematic representation of the EPEC T3SS base showing the SepL binding partners described so far. SepL [green] interacts with EscD [cyan], Tir [black] (Wang et al., 2008), and EscV [red] (this work). In addition, SepL was reported to form two mutually exclusive complexes: the SepL‐EscP [blue] complex, which was proposed to regulate substrate secretion in response to calcium changes in vitro (Shaulov et al., 2017); and the SepL‐SepD [yellow]‐CesL [orange] complex (Younis et al., 2010), whose role in substrate secretion regulation remains to be determined